Frontier Medicines

Frontier Medicines is the developer of a chemoproteomics platform aimed at further accelerating the drug development process. The company’s platform integrates advanced computational methods and machine learning capabilities to discover and pharmacologically target new binding pockets on proteins, making them available for small molecule drug discovery and development, enabling patients to access breakthrough medications that redefine the course of debilitating diseases.